fentaNYL citrate in 0 — Class I drug recall D-1156-2016
Terminated recall by Cantrell Drug Company, reported 2016-07-13, distributed nationwide. Subpotent Drug
| Recall number | D-1156-2016 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Cantrell Drug Company, Little Rock, AR, United States |
| Recall initiated | 2015-08-21 |
| Classified | 2016-07-06 |
| Reported by FDA | 2016-07-13 |
| Terminated | 2017-02-03 |
| Distributed | Nationwide (US) |
| Reason classes | potency |
| NDC | 52533-0214-45, 52533-0214-60 |
| Lot numbers | 148292, 150610, 6208, 6851 |
| Expiration dates | 2015-09-16, 2015-11-09, 2016-01-06, 2016-01-19 |
Product
fentaNYL citrate in 0.9% Sodium Chloride Injection, 5 mcg/1 mL (5 mcg/mL), in a) 1 mL syringe (NDC 52533-214-45, UPC: 0100352533214455) and b) 3 mL syringe (NDC 52533-214-60, UPC: 0100352533214608), Rx Only, Cantrell Drug Co., Little Rock, AR
Reason for recall
Subpotent Drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1156-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.